Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism in patients with inflammatory joint disease - results from the nationwide Norwegian Cardio-rheuma registry.

Eirik IkdahlSilvia RollefstadAmirhossein KazemiSella A ProvanTrine-Lise LarsenAnne Grete Semb

Published in: European heart journal. Cardiovascular pharmacotherapy (2023)

PE rates appeared to be higher in IJD than among non-IJD subjects in our study. tNSAIDs may protect against PE in IJD patients, while coxibs may associated with increased PE risk.

Keyphrases

pulmonary embolism
anti inflammatory drugs
end stage renal disease
ejection fraction
inferior vena cava
newly diagnosed
chronic kidney disease
oxidative stress
peritoneal dialysis
patient reported outcomes
cross sectional